Showing 1 - 5 of 5
When compared against capecitabine alone, the addition of lapatinib has a cost-effectiveness ratio exceeding the threshold normally used by NICE. Compared with T + C, L + C is dominant in the base case and approximately equally likely to be cost-effective in probabilistic sensitivity...
Persistent link: https://www.econbiz.de/10010993884
Pain, depression, osteoarthritis and anxiety/nerves are associated with the greatest losses of HRQoL in the UK population. The estimates presented in this article should be used to inform economic evaluations when assessing health care interventions, though improvements can be made in terms of...
Persistent link: https://www.econbiz.de/10011240887
All SREs were associated with statistically significant utility decreases, suggesting a perceived impact on quality of life beyond the impact of cancer with bone metastases. The resulting disutilities may be used in cost-utility models examining treatments to prevent SREs secondary to bone...
Persistent link: https://www.econbiz.de/10010993892
Recent years have seen increasing interest in the use of ordinal methods to elicit health state utility values as an alternative to conventional methods such as standard gamble and time trade-off (TTO). However, in order to use these ordinal methods to produce health state values for use in...
Persistent link: https://www.econbiz.de/10010593382
Persistent link: https://www.econbiz.de/10009404139